Business Segments · Other segment items
Diabetes — Other segment items
Medtronic Diabetes — Other segment items decreased by 300.0% to -$2.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 86.7%, from -$15.00M to -$2.00M. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryOther
SignalLower is better
VolatilityVolatile
First reportedQ1 2023
Last reportedQ1 2026
How to read this metric
Large, frequent values may indicate underlying operational instability or significant non-recurring events.
Detailed definition
This represents miscellaneous income or expenses specific to the diabetes segment that do not fit into standard categori...
Peer comparison
Standard 'other' or 'unallocated' line item in segment financial reporting.
Metric ID:
mdt_segment_diabetes_other_segment_itemsHistorical Data
11 periods
| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$22.50M | -$22.50M | -$22.50M | -$22.50M | -$9.00M | -$9.00M | -$15.00M | $14.00M | -$3.00M | $1.00M | -$2.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +60.0% | +0.0% | -66.7% | +193.3% | -121.4% | +133.3% | -300.0% |
| YoY Change | — | — | — | — | +60.0% | +60.0% | — | — | +66.7% | +111.1% | +86.7% |
Range-$22.50M – $14.00M
CAGR-62.0%
Avg YoY Growth+76.9%
Median YoY Growth+66.7%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Medtronic's diabetes — other segment items?
- Medtronic (MDT) reported diabetes — other segment items of -$2.00M in Q1 2026.
- How has Medtronic's diabetes — other segment items changed year-over-year?
- Medtronic's diabetes — other segment items increased by 86.7% year-over-year, from -$15.00M to -$2.00M.
- What does diabetes — other segment items mean?
- Miscellaneous costs or gains specific to the diabetes segment that are not part of regular operations.